Celiac.com Sponsor (A1):



Celiac.com Sponsor (A1):


Archived

This topic is now archived and is closed to further replies.

Scott Adams

Biotech vets back $22M A round for neuroscience start-up - FierceBiotech

Recommended Posts

Biotech vets back $22M A round for neuroscience start-up

FierceBiotech

The last heard from Alba was a press release back in early 2011 laying out an option deal that Cephalon had struck for acquiring all the assets related to its lead therapy, larazotide acetate, following a Phase IIb for celiac disease.

and more »

View the full article


Scott Adams

Celiac.com - Celiac Disease Board Moderator

Founder Celiac.com

Share this post


Link to post
Share on other sites

Join eNewsletter


Celiac.com Sponsor (A8):

Celiac.com Sponsor (A8):




Join eNewsletter